BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+17.56%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.54B
AUM Growth
+$331M
(+5.3%)
Cap. Flow
-$370M
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
39.82%
Holding
179
New
25
Increased
33
Reduced
89
Closed
18
Top Buys
| 1 |
Immunocore
IMCR
|
$65.3M |
| 2 |
Biohaven
BHVN
|
$46M |
| 3 |
Moderna
MRNA
|
$41.1M |
| 4 |
GE HealthCare
GEHC
|
$40.4M |
| 5 |
Boston Scientific
BSX
|
$30.3M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$108M |
| 2 |
UnitedHealth
UNH
|
$63.2M |
| 3 |
Evolent Health
EVH
|
$42.9M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$34.5M |
| 5 |
IQVIA
IQV
|
$34M |
Sector Composition
| 1 | Healthcare | 99.06% |
| 2 | Industrials | 0.83% |
| 3 | Energy | 0.03% |
| 4 | Consumer Discretionary | 0.02% |
| 5 | Communication Services | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares MSCI China ETF
MCHI
$7.91B
| $167K | ﹤0.01% |
4,100
| – | – |
|
152
Amneal Pharmaceuticals
AMRX
$3B
| $155K | ﹤0.01% |
+25,470
| New | +$155K |
|
153
Tenet Healthcare
THC
$16.5B
| $109K | ﹤0.01% |
1,447
+747
| +107% | +$56.5K |
|
154
Agilent Technologies
A
$35.5B
| $50.5K | ﹤0.01% |
+363
| New | +$50.5K |
|
155
Qualcomm
QCOM
$170B
| $50.2K | ﹤0.01% |
+347
| New | +$50.2K |
|
156
NVIDIA
NVDA
$4.15T
| $49K | ﹤0.01% |
+990
| New | +$49K |
|
157
Oracle
ORCL
$628B
| $47.9K | ﹤0.01% |
+454
| New | +$47.9K |
|
158
Microsoft
MSFT
$3.76T
| $45.9K | ﹤0.01% |
+122
| New | +$45.9K |
|
159
Mettler-Toledo International
MTD
$26.1B
| $30.3K | ﹤0.01% |
+25
| New | +$30.3K |
|
|
EXAI
160
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $11.3K | ﹤0.01% |
+1,765
| New | +$11.3K |
|
161
IonQ
IONQ
$12.2B
| $9.18K | ﹤0.01% |
+741
| New | +$9.18K |
|
|
PNT
162
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| – | – |
-2,351,160
| Closed | -$15.7M |
|
|
SGEN
163
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-22,000
| Closed | -$4.67M |
|
164
Akero Therapeutics
AKRO
$3.65B
| – | – |
-25,000
| Closed | -$1.26M |
|
|
AMED
165
DELISTED
Amedisys
AMED
| – | – |
-106,387
| Closed | -$9.94M |
|
166
Grupo Aeroportuario del Sureste
ASR
$9.95B
| – | – |
-135
| Closed | -$165 |
|
167
Quest Diagnostics
DGX
$20.1B
| – | – |
-1,324
| Closed | -$161K |
|
168
Equinix
EQIX
$74.6B
| – | – |
-40
| Closed | -$29.1K |
|
169
Evertec
EVTC
$2.2B
| – | – |
-739
| Closed | -$27.5K |
|
170
Guardant Health
GH
$8.11B
| – | – |
-74,525
| Closed | -$2.21M |
|
171
Infosys
INFY
$69B
| – | – |
-1,130
| Closed | -$19.6K |
|
|
172
Jazz Pharmaceuticals
JAZZ
$7.99B
| – | – |
-266,226
| Closed | -$34.5M |
|
173
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-208,745
| Closed | -$6.63M |
|
174
Seer Inc
SEER
$114M
| – | – |
-123,426
| Closed | -$273K |
|
175
TSMC
TSM
$1.2T
| – | – |
-1,089
| Closed | -$1.96K |
|